Get started

More results...

Filter by Content types
Filter by Geography

Alerts LATEST ALERTS

  • Turkey Cannabis use to be expanded to pharmaceutical sector ...
  • Thailand Impact of suspension of prime minister on cannabis ban unclear ...
  • Kazakhstan President signs change to industrial hemp law ...
  • Thailand HHC added to psychotropic substances list ...
  • Thailand Health ministry delays cannabis regulation enforcement ...
  • Thailand DTTAM says cannabis shops with GACP certification can stay open ...
  • Thailand Cannabis restricted to medical use only, with recreational use banned ...
  • Netherlands Coffee shop experiment among ‘controversial’ topics deferred until elections ...
  • United States House votes to let doctors recommend medical cannabis to veterans ...
  • Germany Growing consensus for tighter control over medical cannabis distribution ...
  • Italy Tilray obtains authorisation to distribute medical cannabis ...
  • Arkansas - United States Courts lifts injunction preventing ban on intoxicating hemp-derived products ...
News analysis

Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’

Written by || 17th April 2019 || News analysis | Health and science | Policy and Politics | Regulation and legislation | GeographiesEurope

Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard
Contact a sales agent
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.